Skip to main content
SpringerLink
Log in

Azithromycin bei unkontrolliertem, persistierendem und schwergradigem Asthma bronchiale

Effekte auf die Exazerbationsrate und die Lebensqualität

Azithromycin for uncontrolled, persistent and severe bronchial asthma

Effect on the exacerbation rate and quality of life

  • Journal Club
  • Published:
Der Pneumologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Brusselle GG, Vanderstichele C, Jordens P et al (2013) Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial. Thorax 68:322–329

    Article  PubMed  Google Scholar 

  2. Chung KF, Wenzel SE, Brozek JL et al (2014) International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43:343–373

    Article  PubMed  CAS  Google Scholar 

  3. Gibson PG, Yang IA, Upham JW et al (2017) Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet 390:659–668

    Article  PubMed  CAS  Google Scholar 

  4. Hatchwell L, Collison A, Girkin J et al (2015) Toll-like receptor 7 governs interferon and inflammatory responses to rhinovirus and is suppressed by IL-5-induced lung eosinophilia. Thorax 70:854–861

    Article  PubMed  PubMed Central  Google Scholar 

  5. Kew K, Undela K, Kotortsi I et al (2015) Macrolides for chronic asthma. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.cd002997.pub4

    Article  PubMed  Google Scholar 

  6. Lommatzsch M, Virchow JC (2014) Severe asthma: definition, diagnosis and treatment. Dtsch Ärztebl Int 111:847–855

    PubMed  PubMed Central  Google Scholar 

  7. Vos T, Allen C, Arora M et al (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1545–1602

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lungenklinik, Lehrstuhl für Pneumologie, Kliniken der Stadt Köln gGmbH, Universität Witten/Herdecke, Ostmerheimer Str. 200, 51109, Köln, Deutschland

    T. Schreiber

Authors
  1. T. Schreiber
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Schreiber.

Ethics declarations

Interessenkonflikt

T. Schreiber gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

J. Schreiber, Magdeburg

P. Zabel, Lübeck/Borstel

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schreiber, T. Azithromycin bei unkontrolliertem, persistierendem und schwergradigem Asthma bronchiale. Pneumologe 15, 266–267 (2018). https://doi.org/10.1007/s10405-018-0178-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10405-018-0178-6

Search

Navigation